Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials

BACKGROUND: A one-dose-fits-all approach to use of aspirin has yielded only modest benefits in long-term prevention of cardiovascular events, possibly due to underdosing in patients of large body size and excess dosing in patients of small body size, which might also affect other outcomes. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothwell, Peter M, Cook, Nancy R, Gaziano, J Michael, Price, Jacqueline F, Belch, Jill F F, Roncaglioni, Maria Carla, Morimoto, Takeshi, Mehta, Ziyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083400/
https://www.ncbi.nlm.nih.gov/pubmed/30017552
http://dx.doi.org/10.1016/S0140-6736(18)31133-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083400/
https://www.ncbi.nlm.nih.gov/pubmed/30017552
http://dx.doi.org/10.1016/S0140-6736(18)31133-4

Ejemplares similares